Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response
Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
27434104
PubMed Central
PMC4951142
DOI
10.1371/journal.pone.0159539
PII: PONE-D-16-20256
Knihovny.cz E-zdroje
- MeSH
- Actinobacteria účinky léků fyziologie MeSH
- aktivace lymfocytů účinky léků MeSH
- aminochinoliny farmakologie MeSH
- antibakteriální látky farmakologie MeSH
- buňky Th17 účinky léků imunologie mikrobiologie MeSH
- Clostridiales účinky léků fyziologie MeSH
- druhová specificita MeSH
- exprese genu MeSH
- gnotobiologické modely MeSH
- imichimod MeSH
- interleukin-17 genetika imunologie MeSH
- jaderné receptory - podrodina 1, skupina F, člen 3 genetika imunologie MeSH
- kůže účinky léků imunologie mikrobiologie patologie MeSH
- Lactobacillales účinky léků fyziologie MeSH
- lidé MeSH
- modely nemocí na zvířatech MeSH
- myši inbrední BALB C MeSH
- myši inbrední C57BL MeSH
- myši MeSH
- psoriáza chemicky indukované imunologie mikrobiologie patologie MeSH
- receptory antigenů T-buněk gama-delta genetika imunologie MeSH
- střevní mikroflóra účinky léků fyziologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- aminochinoliny MeSH
- antibakteriální látky MeSH
- imichimod MeSH
- interleukin-17 MeSH
- jaderné receptory - podrodina 1, skupina F, člen 3 MeSH
- receptory antigenů T-buněk gama-delta MeSH
- Rorc protein, mouse MeSH Prohlížeč
Psoriasis is a chronic inflammatory skin disease in which Th17 cells play a crucial role. Since indigenous gut microbiota influences the development and reactivity of immune cells, we analyzed the link among microbiota, T cells and the formation of psoriatic lesions in the imiquimod-induced murine model of psoriasis. To explore the role of microbiota, we induced skin inflammation in germ-free (GF), broad-spectrum antibiotic (ATB)-treated or conventional (CV) BALB/c and C57BL/6 mice. We found that both mice reared in GF conditions for several generations and CV mice treated with ATB were more resistant to imiquimod-induced skin inflammation than CV mice. The ATB treatment dramatically changed the diversity of gut bacteria, which remained stable after subsequent imiquimod application; ATB treatment resulted in a substantial increase in the order Lactobacillales and a significant decrease in Coriobacteriales and Clostridiales. Moreover, as compared to CV mice, imiquimod induced a lower degree of local and systemic Th17 activation in both GF and ATB-treated mice. These findings suggest that gut microbiota control imiquimod-induced skin inflammation by altering the T cell response.
Institute of Experimental Medicine of the Czech Academy of Sciences v v i Prague Czech Republic
Institute of Microbiology of the Czech Academy of Sciences v v i Nový Hrádek Czech Republic
Institute of Microbiology of the Czech Academy of Sciences v v i Prague Czech Republic
Institute of Molecular Genetics of the Czech Academy of Sciences v v i Prague Czech Republic
Zobrazit více v PubMed
Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–85. Epub 2012/09/28. jid2012339 [pii] 10.1038/jid.2012.339 . PubMed DOI
Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009;129(6):1339–50. Epub 2009/03/27. jid200959 [pii] 10.1038/jid.2009.59 . PubMed DOI
Bhatia BK, Millsop JW, Debbaneh M, Koo J, Linos E, Liao W. Diet and psoriasis, part II: celiac disease and role of a gluten-free diet. J Am Acad Dermatol. 2014;71(2):350–8. Epub 2014/05/02. S0190-9622(14)01244-4 [pii] 10.1016/j.jaad.2014.03.017 PubMed DOI PMC
Debbaneh M, Millsop JW, Bhatia BK, Koo J, Liao W. Diet and psoriasis, part I: Impact of weight loss interventions. J Am Acad Dermatol. 2014;71(1):133–40. Epub 2014/04/09. S0190-9622(14)01126-8 [pii] 10.1016/j.jaad.2014.02.012 PubMed DOI PMC
Di Meglio P, Duarte JH, Ahlfors H, Owens ND, Li Y, Villanova F, et al. Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity. 2014;40(6):989–1001. Epub 2014/06/10. S1074-7613(14)00183-6 [pii] 10.1016/j.immuni.2014.04.019 PubMed DOI PMC
Fry L, Baker BS, Powles AV, Fahlen A, Engstrand L. Is chronic plaque psoriasis triggered by microbiota in the skin? Br J Dermatol. 2013;169(1):47–52. Epub 2013/03/26. 10.1111/bjd.12322 . PubMed DOI
Noah PW. The role of microorganisms in psoriasis. Semin Dermatol. 1990;9(4):269–76. Epub 1990/12/01. . PubMed
McFadden JP, Baker BS, Powles AV, Fry L. Psoriasis and streptococci: the natural selection of psoriasis revisited. Br J Dermatol. 2009;160(5):929–37. Epub 2009/03/25. BJD9102 [pii] 10.1111/j.1365-2133.2009.09102.x . PubMed DOI
Naldi L, Peli L, Parazzini F, Carrel CF. Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study. J Am Acad Dermatol. 2001;44(3):433–8. Epub 2001/02/24. S0190-9622(01)37292-4 [pii] 10.1067/mjd.2001.110876 . PubMed DOI
Alekseyenko AV, Perez-Perez GI, De Souza A, Strober B, Gao Z, Bihan M, et al. Community differentiation of the cutaneous microbiota in psoriasis. Microbiome. 2013;1(1):31 Epub 2014/01/24. 2049-2618-1-31 [pii] 10.1186/2049-2618-1-31 PubMed DOI PMC
Gao Z, Tseng CH, Strober BE, Pei Z, Blaser MJ. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One. 2008;3(7):e2719 Epub 2008/07/24. 10.1371/journal.pone.0002719 PubMed DOI PMC
Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485–98. 10.1016/j.cell.2009.09.033 PubMed DOI PMC
Stepankova R, Powrie F, Kofronova O, Kozakova H, Hudcovic T, Hrncir T, et al. Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells. Inflamm Bowel Dis. 2007;13(10):1202–11. Epub 2007/07/04. 10.1002/ibd.20221 . PubMed DOI
Hansen CH, Nielsen DS, Kverka M, Zakostelska Z, Klimesova K, Hudcovic T, et al. Patterns of early gut colonization shape future immune responses of the host. PLoS One. 2012;7(3):e34043 10.1371/journal.pone.0034043 PubMed DOI PMC
Zanvit P, Konkel JE, Jiao X, Kasagi S, Zhang D, Wu R, et al. Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis. Nat Commun. 2015;6:8424 Epub 2015/09/30. ncomms9424 [pii] 10.1038/ncomms9424 ; PubMed Central PMCID: PMC4598725. PubMed DOI PMC
Klimesova K, Kverka M, Zakostelska Z, Hudcovic T, Hrncir T, Stepankova R, et al. Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice. Inflamm Bowel Dis. 2013;19(6):1266–77. 10.1097/MIB.0b013e318281330a PubMed DOI PMC
Hrncir T, Stepankova R, Kozakova H, Hudcovic T, Tlaskalova-Hogenova H. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol. 2008;9:65 Epub 2008/11/08. 1471-2172-9-65 [pii] 10.1186/1471-2172-9-65 PubMed DOI PMC
van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol. 2009;182(9):5836–45. Epub 2009/04/22. 182/9/5836 [pii] 10.4049/jimmunol.0802999 . PubMed DOI
Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ, et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 2010;3(2):148–58. Epub 2009/11/27. mi2009132 [pii] 10.1038/mi.2009.132 PubMed DOI PMC
Reikvam DH, Erofeev A, Sandvik A, Grcic V, Jahnsen FL, Gaustad P, et al. Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS One. 2011;6(3):e17996 Epub 2011/03/30. 10.1371/journal.pone.0017996 PubMed DOI PMC
Zakostelska Z, Kverka M, Klimesova K, Rossmann P, Mrazek J, Kopecny J, et al. Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS One. 2011;6(11):e27961 10.1371/journal.pone.0027961 PubMed DOI PMC
Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–6. Epub 2010/04/13. nmeth.f.303 [pii] 10.1038/nmeth.f.303 PubMed DOI PMC
Bacchetti De Gregoris T, Aldred N, Clare AS, Burgess JG. Improvement of phylum- and class-specific primers for real-time PCR quantification of bacterial taxa. J Microbiol Methods. 2011;86(3):351–6. 10.1016/j.mimet.2011.06.010 . PubMed DOI
Pantelyushin S, Haak S, Ingold B, Kulig P, Heppner FL, Navarini AA, et al. Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J Clin Invest. 2012;122(6):2252–6. Epub 2012/05/02. 61862 [pii] 10.1172/JCI61862 PubMed DOI PMC
Yoshiki R, Kabashima K, Honda T, Nakamizo S, Sawada Y, Sugita K, et al. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing gammadelta T cells. J Invest Dermatol. 2014;134(7):1912–21. Epub 2014/02/27. jid201498 [pii] 10.1038/jid.2014.98 . PubMed DOI
Tlaskalova-Hogenova H, Stepankova R, Kozakova H, Hudcovic T, Vannucci L, Tuckova L, et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol. 2011;8(2):110–20. Epub 2011/02/01. cmi201067 [pii] 10.1038/cmi.2010.67 . PubMed DOI PMC
Gomez de Aguero M, Ganal-Vonarburg SC, Fuhrer T, Rupp S, Uchimura Y, Li H, et al. The maternal microbiota drives early postnatal innate immune development. Science. 2016;351(6279):1296–302. 10.1126/science.aad2571 . PubMed DOI
Flutter B, Nestle FO. TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur J Immunol. 2013;43(12):3138–46. Epub 2013/11/21. 10.1002/eji.201343801 . PubMed DOI
Arck P, Handjiski B, Hagen E, Pincus M, Bruenahl C, Bienenstock J, et al. Is there a 'gut-brain-skin axis'? Exp Dermatol. 2010;19(5):401–5. Epub 2010/02/02. EXD1060 [pii] 10.1111/j.1600-0625.2009.01060.x . PubMed DOI
Bowe W, Patel NB, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicine. Benef Microbes. 2014;5(2):185–99. Epub 2013/07/28. 0U3X16807123W358 [pii] 10.3920/BM2012.0060 . PubMed DOI
Majamaa H, Isolauri E. Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema. J Allergy Clin Immunol. 1996;97(4):985–90. Epub 1996/04/01. S0091674996000899 [pii]. . PubMed
Parodi A, Paolino S, Greco A, Drago F, Mansi C, Rebora A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008;6(7):759–64. Epub 2008/05/06. S1542-3565(08)00155-9 [pii] 10.1016/j.cgh.2008.02.054 . PubMed DOI
Huang BL, Chandra S, Shih DQ. Skin manifestations of inflammatory bowel disease. Front Physiol. 2012;3:13 Epub 2012/02/22. 10.3389/fphys.2012.00013 PubMed DOI PMC
Leffler DA, Green PH, Fasano A. Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol Hepatol. 2015;12(10):561–71. Epub 2015/08/12. nrgastro.2015.131 [pii] 10.1038/nrgastro.2015.131 . PubMed DOI
Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015;67(1):128–39. Epub 2014/10/17. 10.1002/art.38892 PubMed DOI PMC
Weinstock LB, Steinhoff M. Rosacea and small intestinal bacterial overgrowth: prevalence and response to rifaximin. J Am Acad Dermatol. 2013;68(5):875–6. Epub 2013/04/23. S0190-9622(12)02330-4 [pii] 10.1016/j.jaad.2012.11.038 . PubMed DOI
Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy. 1999;29(3):342–6. Epub 1999/04/15. . PubMed
Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997;99(2):179–85. Epub 1997/02/01. S0091674997000304 [pii]. . PubMed
Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy. 2005;60(4):494–500. Epub 2005/02/25. ALL514 [pii] 10.1111/j.1398-9995.2004.00514.x PubMed DOI
Chen L, Zou Y, Peng J, Lu F, Yin Y, Li F, et al. Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis. J Immunol Res. 2015;2015:909514 Epub 2015/05/15. 10.1155/2015/909514 PubMed DOI PMC
Cardone M, Dzutsev AK, Li H, Riteau N, Gerosa F, Shenderov K, et al. Interleukin-1 and interferon-gamma orchestrate beta-glucan-activated human dendritic cell programming via IkappaB-zeta modulation. PLoS One. 2014;9(12):e114516 Epub 2014/12/05. 10.1371/journal.pone.0114516 PONE-D-14-36425 [pii]. PubMed DOI PMC
Johansen C, Mose M, Ommen P, Bertelsen T, Vinter H, Hailfinger S, et al. IkappaBzeta is a key driver in the development of psoriasis. Proc Natl Acad Sci U S A. 2015;112(43):E5825–33. Epub 2015/10/16. 1509971112 [pii] 10.1073/pnas.1509971112 PubMed DOI PMC
Contribution of Infectious Agents to the Development of Celiac Disease
Crucial Role of Microbiota in Experimental Psoriasis Revealed by a Gnotobiotic Mouse Model